Literature DB >> 8896565

An autosomal screen for genes that predispose to celiac disease in the western counties of Ireland.

F Zhong1, C C McCombs, J M Olson, R C Elston, F M Stevens, C F McCarthy, J P Michalski.   

Abstract

Celiac disease is a strongly heritable gastrointestinal illness that is an especially important model of the genetically complex multifactorial immune mediated diseases. The HLA component of celiac disease (a specific HLA-DQ heterodimer)is largely established and is relatively uncomplicated, and the environmental component (gluten and related grain storage proteins in the diet) is remarkably well understood. Previous family studies of celiac disease suggested that there is at least one important non-HLA locus. This locus may be a stronger genetic factor than HLA, and it apparently has a recessive mode of inheritance. We used a three step genome screening protocol to identify loci that contribute to celiac disease in the western counties of ireland, a region with the highest prevalence of celiac disease in the world. The most significant of several possible non-HLA loci that we found was on chromosome 6p about 30 cM telomeric from HLA. It has a multipoint maximum lod score of 4.66 (compared with 4.44 for HLA-DQ) and appears to have a recessive mode of inheritance. Our study localizes and provides strong evidence for linkage of at least one non-HLA locus to celiac disease and may serve as a prototype for an efficient approach to screening the human genome for loci that contribute to complex diseases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8896565     DOI: 10.1038/ng1196-329

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  27 in total

1.  Relative power of linkage and transmission disequilibrium test strategies to detect non-HLA linked coeliac disease susceptibility genes.

Authors:  S Bevan; S Popat; R S Houlston
Journal:  Gut       Date:  1999-11       Impact factor: 23.059

2.  Genomewide linkage analysis of celiac disease in Finnish families.

Authors:  Jianjun Liu; Suh-Hang Juo; Päivi Holopainen; Joseph Terwilliger; Xiaomei Tong; Adina Grunn; Miguel Brito; Peter Green; Kirsi Mustalahti; Markku Mäki; T Conrad Gilliam; Jukka Partanen
Journal:  Am J Hum Genet       Date:  2001-11-19       Impact factor: 11.025

Review 3.  Pathogenesis of coeliac disease: implications for treatment.

Authors:  J S Fraser; P J Ciclitira
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

Review 4.  Genetic factors underlying gluten-sensitive enteropathy.

Authors:  A S Peña; C Wijmenga
Journal:  Curr Allergy Asthma Rep       Date:  2001-11       Impact factor: 4.806

5.  Interplay between genetics and the environment in the development of celiac disease: perspectives for a healthy life.

Authors:  G K Papadopoulos; C Wijmenga; F Koning
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

Review 6.  Genetic aspects of inflammatory bowel disease: how far have we come, and where are we heading?

Authors:  J Cho
Journal:  Curr Gastroenterol Rep       Date:  1999-12

7.  Coeliac disease and schizophrenia: population based case control study with linkage of Danish national registers.

Authors:  William Eaton; Preben Bo Mortensen; Esben Agerbo; Majella Byrne; Ole Mors; Henrik Ewald
Journal:  BMJ       Date:  2004-02-21

Review 8.  Gluten: a two-edged sword. Immunopathogenesis of celiac disease.

Authors:  Frits Koning; Luud Gilissen; Cisca Wijmenga
Journal:  Springer Semin Immunopathol       Date:  2005-08-10

Review 9.  Celiac disease: pathogenesis of a model immunogenetic disease.

Authors:  Martin F Kagnoff
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

10.  Meta-analysis of genome-wide linkage studies in celiac disease.

Authors:  Paola Forabosco; Susan L Neuhausen; Luigi Greco; Asa Torinsson Naluai; Cisca Wijmenga; Paivi Saavalainen; Richard S Houlston; Paul J Ciclitira; Marie-Claude Babron; Cathryn M Lewis
Journal:  Hum Hered       Date:  2009-07-22       Impact factor: 0.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.